NephJC covered the meta-analysis FINE HEARTS
But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction
All content for Freely Filtered, a NephJC Podcast is the property of NephJC Team and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
NephJC covered the meta-analysis FINE HEARTS
But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction
FSGS is hard and the data sucks. But here comes sparsentan fresh off its win in the PROTECT trial for IgA Nephropathy. Can it pull another rabbit out of the hat for patients that suffer from FSGS or are we doomed to forever treating our patients with Acthar® Gel?
Freely Filtered, a NephJC Podcast
NephJC covered the meta-analysis FINE HEARTS
But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction
